These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9561058)

  • 1. Application of superparamagnetic iron oxide (AMI-227) for 3D phase-contrast MR angiography.
    Tanimoto A; Yuasa Y; Hiramatsu K
    Acad Radiol; 1998 Apr; 5 Suppl 1():S113-5. PubMed ID: 9561058
    [No Abstract]   [Full Text] [Related]  

  • 2. Good resolution of contrast-enhanced MRA using USPIO on coronal plane acquisition: experimental evaluation of time-of-flight effect using flow phantom and animal study.
    Tobe K; Yoshikawa K; Seno A; Inoue Y; Tago M; Kazuyuki O; Yoshida H
    Acad Radiol; 1998 Apr; 5 Suppl 1():S116-8. PubMed ID: 9561059
    [No Abstract]   [Full Text] [Related]  

  • 3. The intravascular contrast agent Clariscan (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease.
    Klein C; Nagel E; Schnackenburg B; Bornstedt A; Schalla S; Hoffmann V; Lehning A; Fleck E
    MAGMA; 2000 Nov; 11(1-2):65-7. PubMed ID: 11186991
    [No Abstract]   [Full Text] [Related]  

  • 4. Ultrasmall superparamagnetic iron oxide particles (AMI 227) as a blood pool contrast agent for MR angiography: experimental study in rabbits.
    Loubeyre P; Zhao S; Canet E; Abidi H; Benderbous S; Revel D
    J Magn Reson Imaging; 1997; 7(6):958-62. PubMed ID: 9400837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Three-dimensional MR angiography of HCC and portal and hepatic veins using superparamagnetic iron oxide].
    Ono Y; Marukawa T; Ashikaga R; Inoue M; Fujii K; Araki Y; Ishida O
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Feb; 58(3):97-8. PubMed ID: 9558852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits.
    Taupitz M; Schnorr J; Abramjuk C; Wagner S; Pilgrimm H; Hünigen H; Hamm B
    J Magn Reson Imaging; 2000 Dec; 12(6):905-11. PubMed ID: 11105029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular enhancement with superparamagnetic iron oxide.
    Van Gansbeke D; Matos C; Metens T
    AJR Am J Roentgenol; 1996 Sep; 167(3):813-4. PubMed ID: 8751704
    [No Abstract]   [Full Text] [Related]  

  • 8. MR contrast material for vascular enhancement: value of superparamagnetic iron oxide.
    Mayo-Smith WW; Saini S; Slater G; Kaufman JA; Sharma P; Hahn PF
    AJR Am J Roentgenol; 1996 Jan; 166(1):73-7. PubMed ID: 8571910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superparamagnetic nanoparticles as blood-pool contrast agents. Contribution to MRI preclinical investigations.
    Benderbous S; Bonnemain B
    Radiologe; 1995 Nov; 35(11 Suppl 2):S248-52. PubMed ID: 8588030
    [No Abstract]   [Full Text] [Related]  

  • 10. Ultrasmall superparamagnetic iron oxide-enhanced MR imaging of atherosclerotic plaque in hyperlipidemic rabbits.
    Ruehm SG; Corot C; Vogt P; Cristina H; Debatin JF
    Acad Radiol; 2002 May; 9 Suppl 1():S143-4. PubMed ID: 12019852
    [No Abstract]   [Full Text] [Related]  

  • 11. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
    Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
    Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abdominal MR angiography performed using blood pool contrast agents: comparison of a new superparamagnetic iron oxide nanoparticle and a linear gadolinium polymer.
    Nolte-Ernsting C; Adam G; Bücker A; Berges S; Bjørnerud A; Günther RW
    AJR Am J Roentgenol; 1998 Jul; 171(1):107-13. PubMed ID: 9648772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of AMI-227 as an oral contrast agent for magnetic resonance imaging.
    Rogers J; Lewis J; Josephson L
    Invest Radiol; 1994 Jun; 29 Suppl 2():S81-2. PubMed ID: 7928278
    [No Abstract]   [Full Text] [Related]  

  • 14. NC 100150. (Clariscan, PEG-Ferron).
    Drugs R D; 2002; 3(5):303-4. PubMed ID: 12455149
    [No Abstract]   [Full Text] [Related]  

  • 15. Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence.
    Chambon C; Clement O; Le Blanche A; Schouman-Claeys E; Frija G
    Magn Reson Imaging; 1993; 11(4):509-19. PubMed ID: 8316064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The magnetic properties of some materials affecting MR images.
    Josephson L; Bigler J; White D
    Magn Reson Med; 1991 Dec; 22(2):204-8; discussion 213-5. PubMed ID: 1812347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of USPIO deposition in murine atherosclerosis.
    Klug G; Bauer L; Bauer WR
    Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):E157; author reply E158-9. PubMed ID: 18716317
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary MR angiography with ultrasmall superparamagnetic iron oxide particles as a blood pool agent and a navigator echo for respiratory gating: pilot study.
    Ahlström KH; Johansson LO; Rodenburg JB; Ragnarsson AS; Akeson P; Börseth A
    Radiology; 1999 Jun; 211(3):865-9. PubMed ID: 10352617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of intravascular contrast agents in MRI.
    Bjørnerud A; Wendland MF; Johansson L; Ahlstrom HK; Higgins CB; Oksendal A
    Acad Radiol; 1998 Apr; 5 Suppl 1():S223-5. PubMed ID: 9561086
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of AMI-227 as an oral MR contrast agent.
    Rogers J; Lewis J; Josephson L
    Magn Reson Imaging; 1994; 12(4):631-9. PubMed ID: 8057768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.